Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16624163 | 0.93 | SMN1; SMN2 (0.42) | SMN1; SMN2LMNAMAPTMITFRAB9A | |
| SCHEMBL16624161 | 0.90 | CHRNB2 (0.39) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL16624159 | 0.85 | TRPV1 (0.40) | — | |
| SCHEMBL16624912 | 0.75 | NPSR1 (0.48) | SMN1; SMN2LMNAMAPTMITFRAB9A | |
| SCHEMBL16624893 | 0.74 | MEN1 (0.48) | SMN1; SMN2LMNAALDH1A1TSHRMEN1 | |
| SCHEMBL16624901 | 0.73 | F2 (0.46) | LMNARAB9AALDH1A1TSHRMEN1 | |
| SCHEMBL16624157 | 0.71 | HRH3 (0.32) | SMN1; SMN2ALDH1A1HPGDCHRM3CHRM2 | |
| SCHEMBL16624154 | 0.71 | HRH3 (0.32) | SMN1; SMN2ALDH1A1CHRM3CHRM2 | |
| SCHEMBL16624153 | 0.70 | HRH3 (0.32) | SMN1; SMN2ALDH1A1HPGDCHRM3CHRM2 | |
| SCHEMBL16624910 | 0.69 | SMN1; SMN2 (0.46) | SMN1; SMN2LMNAMAPTMITFRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9730875-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9730875-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2017-08-15 | — | — | US | disclosed |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA | 2016-05-26 | — | — | US | disclosed |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA | 2016-05-26 | — | — | US | disclosed |
| US-9284261-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-03-15 | — | — | US | disclosed |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | SMN1; SMN2 2945/4885LMNA 1414/4885MAPT 1946/4885 |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | SMN1; SMN2 2945/4885LMNA 1414/4885MAPT 1946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.